search
Company Information
USD
5.17
- (0.4%)
NASDAQ:DTIL, PRECISION BIOSCIENCES, INC.
Industry: Biotechnology
End of Day: 9 May 2025 GMT-4
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

Address

302 East Pettigrew Street
Dibrell Building, Suite A-100

Classification

Sector

Healthcare

Industry Group

Biotechnology

Industry

Biotechnology

Key Executives

Mr. John Alexander Kelly
CFO/Chief Accounting Officer
Dr. Derek Jantz, PhD
Co-Founder/Other Executive Officer
Ms. Mei Burris
Controller/Vice President
Mr. Geno J. Germano
Director
Mr. Kevin J. Buehler
Chairman of the Board/Director
Dr. Samuel C. Wadsworth, PhD
Director
Ms. Melinda Brown
Director
Mr. Dario Scimeca
General Counsel/Secretary
Mr. Michael Amoroso
CEO/Director/President
Dr. Stanley R. Frankel, M.D.
Director
Dr. Alan List, M.D.
Chief Medical Officer
Ms. Shari Lisa Pire, J.D.
Director
Mr. Jeff Smith
Co-Founder/Other Executive Officer

Ownership

Institution Holdings

Tang Capital Partners LP
6,400,000 (5.249%)
Capital World Investors
5,119,458 (4.199%)
Capital Research and Management Company
5,119,458 (4.199%)
Vanguard Group Inc
4,693,076 (3.849%)
Eli Lilly and Co
3,762,190 (3.086%)
Acadian Asset Management LLC
3,343,914 (2.743%)
Citadel Advisors Llc
3,133,909 (2.570%)
Renaissance Technologies Corp
2,591,212 (2.125%)
Vanguard Investments Australia Ltd
2,436,959 (1.999%)
Stifel Financial Corp
1,545,850 (1.268%)

Individual Holdings

Dr. Derek Jantz, PhD
4,055,174 (6.522%)
Mr. Jeff Smith
1,987,269 (1.630%)
Mr. John Alexander Kelly
614,169 (0.504%)
Mr. Michael Amoroso
356,433 (0.292%)
Mr. Dario Scimeca
151,028 (0.124%)
Dr. Alan List, M.D.
94,982 (0.078%)
Mr. Kevin J. Buehler
5,701 (0.005%)
Dr. Stanley R. Frankel, M.D.
1,500 (0.003%)

Funds Holdings

Vanguard US Total Market Shares ETF
2,436,959 (1.999%)
Fidelity Extended Market Index Fund
501,800 (0.412%)
Jacob Discovery Fund
307,700 (0.252%)
BlackRock Extended Equity Market
178,003 (0.146%)
Harbor Disruptive Innovation Fund
102,709 (0.084%)
NT Ext Equity Mkt Idx Fd - DC - NL
54,739 (0.045%)
Harbor Disruptive Innovation ETF
1,537 (0.038%)
Spartan Extended Market Index Pool
23,137 (0.019%)
Extended Equity Market Fund M
22,009 (0.018%)
BlackRock U.S. Equity Market
17,666 (0.014%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices